Future studies should explore the long-term effects of ALC supplementation, use high-throughput techniques to uncover detailed mechanisms, and conduct large-scale clinical trials to confirm its therapeutic potential
Patients with a history of malignancy, organ transplantation, or pre-existing dermatologic conditions of interestincluding atopic dermatitis, psoriasis, vitiligo, pemphigus, bullous pemphigoid, dermatomyositis, alopecia areata, lichen planus, cutaneous lupus erythematosus, hidradenitis suppurativa, systemic sclerosis, pyoderma gangrenosum, and morpheawere excluded at baseline
National Institute of Diabetes and Digestive and Kidney Disease
Our providers document why a compounded alternative is clinically appropriate before prescribing